2023 annual financial data
BriaCell Therapeutics Corp. - Common Shares 2023 Operating margin
BriaCell Therapeutics Corp. - Common Shares 2023 operating margin with verified…
Direct answer
Operating margin was Not calculable.
Operating income was -31,080,690 USD and net income was -27,114,354 USD.
Operating cash flow was -31,891,100 USD.
Get free BriaCell Therapeutics Corp. - Common Shares email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -31,080,690 USD
- Net income
- -27,114,354 USD
- Operating cash flow
- -31,891,100 USD
Explore related company data
View all 2023 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Net marginView Operating cash flow marginView all BriaCell Therapeutics Corp. - Common Shares financial years